Assyro AI

Orange Book product · Generic (ANDA)

CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY

CETIRIZINE HYDROCHLORIDE

Generic (ANDA)ANDA 212266OTC QUAGEN

At a glance

May 16, 2019

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    May 16, 2019

    7 yr 2 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

CETIRIZINE HYDROCHLORIDE

Strength

5MG/5ML

Dosage form

SOLUTION

Route

ORAL

TE code

Not listed

Application

ANDA 212266

Product number

001

Marketing status

OTC

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of CETIRIZINE HYDROCHLORIDE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.